A significant advance in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This essential malignant protector protein is frequently disabled in various forms of cancer, resulting https://zbookmarkhub.com/story22121387/vhh-fragments-revive-the-p53-protein-the-potential-pathway-for-malignant-therapy